Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for January 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Strategies Presented for Addressing Uncompensated Time
THURSDAY, Jan. 26, 2017 (HealthDay News) — Strategies can be employed to help physicians deal with the increasing burden of uncompensated tasks, according to an article published in Medical Economics.
Most PCPs Oppose Complete Repeal of the Affordable Care Act
THURSDAY, Jan. 26, 2017 (HealthDay News) — A majority of primary care doctors oppose full repeal of the Affordable Care Act, according to a perspective piece published online Jan. 25 in the New England Journal of Medicine.
Verapamil Benefits Chronic Rhinosinusitis With Nasal Polyps
THURSDAY, Jan. 26, 2017 (HealthDay News) — For patients with chronic rhinosinusitis with nasal polyps (CRSwNP), the first-generation inhibitor of epithelial P-glycoprotein (P-gp; an efflux pump that is overexpressed in CRSwNP), verapamil hydrochloride (HCl), is associated with improvement in outcome measures, according to a letter to the editor study published online Jan. 23 in the Journal of Allergy and Clinical Immunology.
Full Text (subscription or payment may be required)
Obesity Underrepresented in Medical Licensing Exams
FRIDAY, Jan. 20, 2017 (HealthDay News) — The most important concepts of obesity prevention and treatment are not adequately represented on the U.S. Medical Licensing Examination (USMLE) Step examinations, according to a study published recently in Teaching and Learning in Medicine.
Full Text (subscription or payment may be required)
Cognitive Training Can Positively Affect Perception of Tinnitus
FRIDAY, Jan. 20, 2017 (HealthDay News) — An internet-based program to improve mental acuity may help patients cope with tinnitus, according to a study published online Jan. 19 in JAMA Otolaryngology-Head & Neck Surgery.
Body Dysmorphic Disorder Often Missed by Plastic Surgeons
WEDNESDAY, Jan. 18, 2017 (HealthDay News) — Nearly one in 10 patients seeking facial plastic surgery suffers from body dysmorphic disorder (BDD), but doctors often don’t spot the problem, according to research published online recently in JAMA Facial Plastic Surgery.
Full Text (subscription or payment may be required)
Current Guidelines for Pediatric Tonsillectomies Questioned
TUESDAY, Jan. 17, 2017 (HealthDay News) — Researchers evaluating evidence for tonsillectomy found that more children would receive significant short-term improvement in their daily life if the current guidelines were relaxed. The two reviews were published online Jan. 17 in Pediatrics.
Full Text 1 (subscription or payment may be required)
Full Text 2 (subscription or payment may be required)
Physician Excess Charges Create Financial Burden for Patients
TUESDAY, Jan. 17, 2017 (HealthDay News) — Many doctors bill their private-paying patients two, three, even six times more than what Medicare pays for the same services, according to a research letter published in the Jan. 17 issue of the Journal of the American Medical Association.
Full Text (subscription or payment may be required)
Allergy Diary Phone App Classifies Phenotypes in Rhinitis
FRIDAY, Jan. 13, 2017 (HealthDay News) — The Allergy Diary phone app can identify phenotypic differences between rhinitis groups, according to a study published online Jan. 10 in Allergy.
Full Text (subscription or payment may be required)
Excessive FDA Regulation Driving High Drug Prices
WEDNESDAY, Jan. 11, 2017 (HealthDay News) — The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices, and should be curbed to introduce more competition and lower prices, according to a report published online Jan. 5 by the National Center for Policy Analysis.
Complications in One-Third Undergoing Total Laryngectomy
WEDNESDAY, Jan. 11, 2017 (HealthDay News) — About one-third of patients undergoing total laryngectomy (TL) have complications and 13.9 percent are readmitted within 30 days, according to a study published online Dec. 27 in Cancer.
Full Text (subscription or payment may be required)
Inflammatory Markers Prognostic in Primary Sinonasal Cancer
TUESDAY, Jan. 10, 2017 (HealthDay News) — Pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) can predict survival for patients with primary sinonasal cancers (SNCs), according to a study published online Dec. 29 in Head & Neck.
Full Text (subscription or payment may be required)
HRQoL Down for GERD With Laryngopharyngeal Reflux
MONDAY, Jan. 9, 2017 (HealthDay News) — For patients with gastroesophageal reflux disease (GERD), the presence of laryngopharyngeal reflux symptoms (LPR) is associated with reduced health-related quality of life (HRQoL), according to a study published online Jan. 3 in the Journal of Gastroenterology and Hepatology.
Full Text (subscription or payment may be required)
Food Additives May Play Role in Recurrent Aphthous Stomatitis
THURSDAY, Jan. 5, 2017 (HealthDay News) — Food additives may play a role in the etiology of recurrent aphthous stomatitis (RAS), according to a study published online Dec. 30 in the International Journal of Dermatology.
Full Text (subscription or payment may be required)
Cancer Mortality Rates Continue to Decline in the United States
THURSDAY, Jan. 5, 2017 (HealthDay News) — Cancer mortality rates in the United States have dropped 25 percent since the early 1990s, according to a new report published online Jan. 5 in CA: A Cancer Journal for Clinicians.
Artificial Larynx Implant Feasible After Total Laryngectomy
THURSDAY, Jan. 5, 2017 (HealthDay News) — An artificial larynx has provided long-term relief for a throat cancer patient in France who had a total laryngectomy, according to a letter to the editor published in the Jan. 5 issue of the New England Journal of Medicine.
Cancer Cachexia Associated With Poor Outcomes
WEDNESDAY, Jan. 4, 2017 (HealthDay News) — Patients with sustained or newly developed cancer cachexia at six and 12 months after initial treatment for advanced head and neck squamous cell carcinoma (HNSCC) are at higher risk of cancer recurrences, the onset of non-cancer health events, and poor survival outcomes, according to a study published online Dec. 21 in Head & Neck.
Full Text (subscription or payment may be required)
Copyright © 2017 ScoutNews, LLC. All rights reserved.
